# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4581647 | 13 | Stability | = | 92 | % | ALA4424114 | % | Homo sapiens | |||
2. | ALA4581647 | 13 | Stability | = | 121 | % | ALA4424113 | % | Homo sapiens | |||
3. | ALA4581647 | 13 | Stability | = | 123 | % | ALA4424112 | % | Homo sapiens | |||
4. | ALA4581647 | 13 | Stability | = | 100 | % | ALA4424111 | % | Homo sapiens | |||
5. | ALA4848094 | 29 | t1/2 | > | 120 | min | ALA4824886 | hr | Homo sapiens | |||
6. | ALA4846036 | 44 | Stabilty | = | 104 | % | ALA4812148 | % | Homo sapiens | |||
7. | ALA4846036 | 44 | Stabilty | = | 106 | % | ALA4812147 | % | Homo sapiens | |||
8. | ALA4846036 | 44 | Stabilty | = | 100 | % | ALA4812146 | % | Homo sapiens | |||
9. | Combretastatin A4 | CA-4 | CLH | = | 0.98 | microL/min/mg | ALA4684067 | mL.min-1.g-1 | Homo sapiens | |||
10. | ALA4759508 | 46 | CLH | = | 14.2 | microL/min/mg | ALA4684067 | mL.min-1.g-1 | Homo sapiens | |||
11. | ALA4784818 | 11; D-788819 | CLH | = | 645 | microL/min/mg | ALA4684067 | mL.min-1.g-1 | Homo sapiens | |||
12. | Combretastatin A4 | CA-4 | t1/2 | = | 2.71 | min | ALA4684066 | hr | Homo sapiens | |||
13. | ALA4759508 | 46 | t1/2 | = | 98 | min | ALA4684066 | hr | Homo sapiens | |||
14. | ALA4784818 | 11; D-788819 | t1/2 | = | 1410 | min | ALA4684066 | hr | Homo sapiens | |||
15. | BMS-986242 | 25; BMS-986242 | t1/2 | = | 120 | min | ALA4679991 | hr | Homo sapiens | |||
16. | ALA4446605 | 11 | Stability | = | 100 | % | ALA4415711 | % | Homo sapiens | |||
17. | ALA4446605 | 11 | Stability | = | 99 | % | ALA4415710 | % | Homo sapiens | |||
18. | ALA4446605 | 11 | Stability | = | 99 | % | ALA4415709 | % | Homo sapiens | |||
19. | ALA4446605 | 11 | Stability | = | 100 | % | ALA4415708 | % | Homo sapiens | |||
20. | Retigabine | 1 (Retigabine) | Drug metabolism | = | 11.41 | % | ALA4403841 | % | Homo sapiens |